Promising Results For Glivec In CML Continue, FDA Grants Priority Review
High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I
Wilms’ Tumor Survivors At High Risk Of Heart Failure
Cancer Pain Treatment Guide Published By NCCN, ACS
Without Advance Directives, Families Prolong Treatment
Long-Term Estrogen Use May Increase Ovarian Cancer Risk
Natural Substance Blocks Androgen Activity In Vitro
NCI-Approved Clinical Trials Listed For Month Of March
Trending Stories
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- ACOG says it will no longer accept federal funding
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death
